Green Thumb Industries (GTBIF) Asset Writedowns and Impairment (2022 - 2024)
Green Thumb Industries' (GTBIF) quarterly Asset Writedowns and Impairment came in at $231000.0 in Q3 2024, up 165.52% YoY from $87000.0 in Q4 2023, and down 95.71% on a QoQ basis from $5.4 million in Q4 2023.
Green Thumb Industries (GTBIF) Asset Writedowns and Impairment (2022 - 2024) Analysis & Trends
Green Thumb Industries (GTBIF) has 3 years of Asset Writedowns and Impairment data on file, last reported at $231000.0 in Q3 2024.
- Quarterly Asset Writedowns and Impairment rose 165.52% year-over-year to $231000.0 in Q3 2024, while the trailing twelve-month figure through Dec 2025 was $231000.0 (down 95.95% YoY) and the FY2024 annual result came in at $450000.0, down 91.77% from the prior year.
- Asset Writedowns and Impairment retreated to $231000.0 in Q3 2024, from $5.4 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $88.5 million in Q4 2022 to a low of $87000.0 in Q3 2023.
- A 3-year average of $23.6 million and a median of $2.8 million in 2023 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment sank 93.92% — and 2024, when it surged 165.52%.
- Tracing GTBIF's Asset Writedowns and Impairment over 3 years: stood at $88.5 million in 2022, then slumped by 93.92% to $5.4 million in 2023, then tumbled by 95.71% to $231000.0 in 2024.
- The last three Asset Writedowns and Impairment figures came in at $231000.0 (Q3 2024), $5.4 million (Q4 2023), and $87000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 231,000.00 |
| Sep 30, 2024 | 231,000.00 |
| Dec 31, 2023 | 5.38 Mn |
| Dec 31, 2023 | 5.38 Mn |
| Sep 30, 2023 | 87,000.00 |
| Sep 30, 2023 | 87,000.00 |
| Dec 31, 2022 | 88.50 Mn |
| Dec 31, 2022 | 88.50 Mn |